Neuron23 snags US$100 million for AI drug discovery

Apr 4, 2022

Related news

Oct 7
,
2021
AI
Cleantech
Healthcare
Investment
Life Science
Press

Amazon Genomics CLI is Open Source, UK Biobank’s Research Analysis Platform Live

Nov 15
,
2021
AI
Cleantech
Healthcare
Investment
Life Science
Press

Investment Into Biosciences Boomed, Could The Bubble Burst?

Sep 30
,
2021
AI
Cleantech
Healthcare
Investment
Life Science
Press

Government to nurture AI-specializing medical scientists

Nov 22
,
2021
AI
Cleantech
Healthcare
Investment
Life Science
Press

Most Important Technologies in 2022

Nov 2
,
2021
AI
Cleantech
Healthcare
Investment
Life Science
Press

Four major impacts of artificial intelligence on healthcare

Oct 19
,
2021
AI
Cleantech
Healthcare
Investment
Life Science
Press

Venture capital firm Sofinnova raises 472 mln euros to focus on healthcare start-ups

Sep 27
,
2021
AI
Cleantech
Healthcare
Investment
Life Science
Press

Drug discovery platform Exscientia sets terms for $275 million US IPO

Sep 22
,
2021
AI
Cleantech
Healthcare
Investment
Life Science
Press

Arabesque launches the world’s first AI-powered ESG portfolio manager

Sep 21
,
2021
AI
Cleantech
Healthcare
Investment
Life Science
Press

Interest in sustainable investing is at an all-time high

Mar 29
,
2022
AI
Cleantech
Healthcare
Investment
Life Science
Press

3 Myths About Women Working in Tech, Busted

Feb 1
,
2022
AI
Cleantech
Healthcare
Investment
Life Science
Press

ALPHA10X Emerges from Stealth With $9.4 Million In Seed Funding

Feb 21
,
2022
AI
Cleantech
Healthcare
Investment
Life Science
Press

Innovative AI-powered Search and Discovery Platform; Interview With Robert Marcus